title: Facilitated PCI in younger Chinese patients with AMI.
abstract: Presently, facilitated percutaneous coronary intervention (PCI) in patients remains controversial. We evaluated the efficacy and safety of facilitated PCI, intravenous low-dose rt-PA administration prior to urgent PCI, in Chinese patients < 70 years of age with ST-segment elevation myocardial infarction. Our results suggest that the age and dosage of thrombolytics should be noticed seriously when considering facilitated PCI.
authors.forename: Feng
authors.initials: F
authors.lastname: Xu
authors.forename: Yu-guo
authors.initials: YG
authors.lastname: Chen
authors.forename: Ji-fu
authors.initials: JF
authors.lastname: Li
authors.forename: Gui-shuang
authors.initials: GS
authors.lastname: Li
authors.forename: Qiu-shang
authors.initials: QS
authors.lastname: Ji
authors.forename: Rui-juan
authors.initials: RJ
authors.lastname: Lv
authors.forename: Tong-tao
authors.initials: TT
authors.lastname: Liu
authors.forename: Yi
authors.initials: Y
authors.lastname: Sun
authors.forename: Rui-jian
authors.initials: RJ
authors.lastname: Li
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
authors.forename: Yun
authors.initials: Y
authors.lastname: Zhang
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D002681:China; D017023:Coronary Angiography; D003326:Coronary Circulation; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*; D012189:Retrospective Studies; D015607:Stents; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014654:Vascular Patency
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator